article thumbnail

Industry Groups Provide Feedback on Sen. Warner’s ‘Cybersecurity is Patient Safety’ White Paper

HIPAA Journal

Mark Warner (D-Va) recently published a white paper framing cybersecurity as a patient safety issue. Warner says the white paper is a starting point to open up a discussion about changes that can be implemented to improve cybersecurity in the sector, rather than a blueprint for change.

HIPAA 107
article thumbnail

Cybersecurity is Now a Patient Safety Issue, Suggests Sen. Warner In Congressional Report

HIPAA Journal

Warner suggests the only way to improve healthcare cybersecurity rapidly is through a collaborative effort involving the public and private sectors, with the federal government providing overall leadership. The white paper suggests several areas where policies could be changed to improve cybersecurity in the healthcare industry.

HIPAA 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What If Costco Designed the Prescription Drugs Sales Model?

Health Populi

In 2006 the Medicare Part D program was implemented, covering older Americans for prescription drugs for the first time. Medicare further drove expansion of generic drug utilization, with co-pays for generics lower for Medicare enrollees than branded drugs. While these four actions to lower drug costs garner over 80% of U.S.

article thumbnail

CMS Innovation Center Redesigns Direct Contracting Entity Model, Launches ACO REACH

C&M Health Law

The most recent example, announced late last month, includes the redesign and renaming of the controversial Global and Professional Direct Contracting (GPDC) model that aims to introduce value-based payment arrangements in traditional Medicare. CMS’ decision to redesign the GDPC model has been met with mixed reactions from stakeholders.

article thumbnail

White House looks to CMMI to test new ways to lower drug prices

C&M Health Law

The EO comes two months after the president signed the Inflation Reduction Act (IRA) which promises to lower the cost of prescription drugs for many Medicare beneficiaries. This is not the first time that the White House will try to leverage CMMI’s testing authority to create models that would lower drug costs in Medicare.